-
1دورية أكاديمية
المؤلفون: Schernthaner, G., Barnett, A. H., Betteridge, D. J., Carmena, R., Ceriello, A., Charbonnel, B., Hanefeld, M., Lehmann, R., Malecki, M. T., Nesto, R., Pirags, V., Scheen, André, Seufert, J., Sjoholm, A., Tsatsoulis, A., Defronzo, R.
المصدر: Diabetologia (2010)
مصطلحات موضوعية: EASD consensus statement, ovascular risk . Type 2 diabetes, Hyperglycaemia, Glucose-lowering therapy, Consensus Statement, Algorithm, cardiovascular risk, Human health sciences, Endocrinology, metabolism & nutrition, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition
العلاقة: http://www.springerlink.com/content/11115287k1101761/fulltext.pdfTest; urn:issn:0012-186X; urn:issn:1432-0428; https://orbi.uliege.be/handle/2268/4866Test; info:hdl:2268/4866; https://orbi.uliege.be/bitstream/2268/4866/1/Is%20the%20ADA%20EASD%20algorithm%20for%20the%20management_ocr.pdfTest; scopus-id:2-s2.0-77955657408; info:pmid:20352408
الإتاحة: https://doi.org/10.1007/s00125-010-1702-3Test
https://orbi.uliege.be/handle/2268/4866Test
https://orbi.uliege.be/bitstream/2268/4866/1/Is%20the%20ADA%20EASD%20algorithm%20for%20the%20management_ocr.pdfTest -
2
المؤلفون: Bernard Charbonnel, Roger Lehmann, Valdis Pirags, D. J. Betteridge, Richard W. Nesto, Agathocles Tsatsoulis, Antonio Ceriello, Markolf Hanefeld, A. H. Barnett, Ralph A. DeFronzo, R. Carmena, Maciej T. Malecki, André Scheen, Guntram Schernthaner, Jochen Seufert, Åke Sjöholm
المساهمون: University of Zurich, Schernthaner, G
المصدر: Diabetologia Vol. 53 Issue 7: pp. 1258-1269
Diabetologia
RODERIC. Repositorio Institucional de la Universitat de Valéncia
instnameمصطلحات موضوعية: cardiovascular risk, Glucose-lowering therapy, Endocrinology, Diabetes and Metabolism, education, Societies, Medical/standards, MEDLINE, 10265 Clinic for Endocrinology and Diabetology, Hypoglycemic Agents/therapeutic use, 610 Medicine & health, Type 2 diabetes, Hyperglycemia/drug therapy, Lifestyle modification, Risk Factors, Diabetes mellitus, Tier 2 network, ADA Consensus Statement, medicine, Internal Medicine, Initial treatment, Hyperglycaemia, Humans, In patient, For Debate, algorithm, business.industry, nutritional and metabolic diseases, medicine.disease, Cardiovascular risk, United States, Metformin, EASD consensus statement, glucose-lowering therapy, Algorithm, Europe, 2712 Endocrinology, Diabetes and Metabolism, 2724 Internal Medicine, Algorithms, Diabetes Mellitus, Type 2/complications/*drug therapy, type 2 diabetes, business, Cardiovascular Diseases/prevention & control, hyperglycaemia, medicine.drug
وصف الملف: Is_the_ADA-EASD_algorithm-RL.pdf - application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5d725896518bad4ddcd72275c33a383Test
https://doi.org/10.5167/uzh-44492Test